In T2DM, a significantly increased level of plasma clusterin was found (Trougakos et al., 2002) and clusterin might be an useful biomarker for detecting the early stage of diabetic retinopathy (Jin et al., 2016). The gene discussed is CLU; the disease is diabetic retinopathy.